✦ LIBER ✦

Treatment of acute rejection of human renal allograft by OKT3 pan

✍ Scribed by E. Rivolta; A. De Vecchi; A. Tarantino; F. Egidi; C. Ponticelli

Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 50 KB
Volume: 7
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(85)90460-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reversal of acute glomerular renal allog

Reversal of acute glomerular renal allograft rejection: a possible effect of OKT3

✍ A. D. Hibberd; R. S. Nanra; K. H. White; P. R. Trevillian 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 587 KB

Long-term outcome of the use of OKT3 to

Long-term outcome of the use of OKT3 to treat steroid-resistant acute renal allograft rejection

✍ Peter A. Rowe; Kin S. Fan; D. Stuart Gardiner; Stuart G. Macpherson; J. Andrew B 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 596 KB

Evaluation of OKT3 monoclonal antibody a

Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants

✍ Manuel Mochon; Bruce Kaiser; Jo Ann Palmer; Martin Polinsky; Joseph T. Flynn; G. 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 531 KB

Local graft irradiation in treatment of

Local graft irradiation in treatment of acute rejection of human renal transplant

✍ Aly A. Razek; Kirk H. Packo; Charles B. Anderson 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 77 KB

The effect of locally synthesised comple

The effect of locally synthesised complement on acute renal allograft rejection

✍ Steven Sacks; Wuding Zhou 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 219 KB

Use of lymphoplasmapheresis or plasmaphe

Use of lymphoplasmapheresis or plasmapheresis in the management of acute renal allograft rejection

✍ Steven Kleinman; Marcus Nichols; Franklin Strauss; Dennis Goldfinger 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

## Abstract Several recent reports have documented the value of intensive plasmapheresis as an adjunct to standard immunosuppressive therapy for patients suffering acute renal allograft rejection. We have treated four rejection episodes in three patients with intensive plasmapheresis and two reject